Summary:
The global biosimilar market size reached USD 21.2 billion in 2023.
The market is expected to reach USD 164.5 Billion by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032.
Europe leads the market, accounting for the largest biosimilar market share.
Infliximab accounts for the majority of the market share in the molecule segment as it is a highly sought-after biosimilar...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian